Porcine reproductive and respiratory syndrome virus vaccines: Immunogenicity, efficacy and safety aspects

doi:10.5501/wjv.v1.i1.23

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 1, Issue 1

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7147)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-4) series.

Item

Count

PDF

900

HTML

5884

Tables (1-4)

363

Sum=7147

Feb 12, 2012 (publication date) through Apr 23, 2024

Times Cited of This Article

Times Cited (129)

Journal Information of This Article

Publication Name

World Journal of Virology

ISSN

2220-3249

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Guidelines For Clinical Practice

World J Virol . Feb 12, 2012; 1(1): 23-30
Published online Feb 12, 2012. doi: 10.5501/wjv.v1.i1.23

Porcine reproductive and respiratory syndrome virus vaccines: Immunogenicity, efficacy and safety aspects

Wasin Charerntantanakul

Wasin Charerntantanakul, Research Laboratory for Immunity Enhancement in Humans and Domestic Animals, Program of Biotechnology, Faculty of Science, Maejo University, Chiang Mai 50290, Thailand

Author contributions: Charerntantanakul W solely contributed to this paper.

Supported by The Thailand Research Fund, NO. DIG5180032

Correspondence to: Wasin Charerntantanakul, DVM, PhD, Assistant Professor, Director, Research Laboratory for Immunity Enhancement in Humans and Domestic Animals, Program of Biotechnology, Faculty of Science, Maejo University, Chiang Mai 50290, Thailand. wasin@mju.ac.th

Telephone: +66-53-873535-117 Fax: +66-53-878225

Received: July 13, 2011
Revised: September 21, 2011
Accepted: September 29, 2011
Published online: February 12, 2012

Core Tip